145 related articles for article (PubMed ID: 88813)
21. Immunogenic and antigenic epitopes of immunoglobulins--VII. The topographical distribution of Fc gamma epitopes and the relationship of an iso-allotypic specificity to the presence of histidine 435.
Nik Jaafar MI; Lowe JA; Ling NR; Jefferis R
Mol Immunol; 1984 Feb; 21(2):137-43. PubMed ID: 6200772
[TBL] [Abstract][Full Text] [Related]
22. The primary structure of mu-chain-disease protein BOT. Peculiar amino-acid sequence of the N-terminal 42 positions.
Barnikol-Watanabe S; Mihaesco E; Mihaesco C; Barnikol HU; Hilschmann N
Hoppe Seylers Z Physiol Chem; 1984 Jan; 365(1):105-18. PubMed ID: 6425189
[TBL] [Abstract][Full Text] [Related]
23. Physicochemical and immunological properties of a mu chain disease protein.
Mihaesco C; Mihaesco E; Miglierina R; Lamaziere J; Roy JP; Seligmann M
Immunochemistry; 1976 Jan; 13(1):39-45. PubMed ID: 815173
[No Abstract] [Full Text] [Related]
24. A new case of gamma-heavy chain disease. Clinical and immunochemical studies.
Cozzolino F; Vercelli D; Castigli E; Becucci A; Di Guglielmo R
Scand J Haematol; 1982 Feb; 28(2):145-50. PubMed ID: 6806895
[No Abstract] [Full Text] [Related]
25. Immunochemical study of a human myeloma IgG1 half molecule.
Seligmann M; Mihaesco E; Chevalier A; Miglierina R
Ann Immunol (Paris); 1978; 129 C(6):855-70. PubMed ID: 85430
[TBL] [Abstract][Full Text] [Related]
26. Immunological and biochemical studies of an unusual alpha heavy chain protein in a 9-year-old boy.
Joller PW; Joller-Jemelka HI; Shmerling DH; Skvaril F
J Clin Lab Immunol; 1984 Nov; 15(3):167-72. PubMed ID: 6442353
[TBL] [Abstract][Full Text] [Related]
27. An unusual case of a plasma cell neoplasm with an IgG3lambda myeloma and a gamma3 heavy chain disease protein.
Adlersberg JB; Grann V; Zucker-Franklin D; Frangione B; Franklin EC
Blood; 1978 Jan; 51(1):85-96. PubMed ID: 412532
[TBL] [Abstract][Full Text] [Related]
28. [Immunological aspects of alpha chain disease (author's transl)].
Seligmann M; Danon F; Preud'homme JL; Brouet JC
Acta Gastroenterol Belg; 1978; 41(5-6):264-71. PubMed ID: 100998
[No Abstract] [Full Text] [Related]
29. Physicochemical and immunochemical properties of gamma l heavy chain disease protein BAZ.
Smith LL; Barton BP; Garver FA; Chang LS; McGuire B; Faguet GB; Lutcher CL
Immunochemistry; 1978 May; 15(5):323-9. PubMed ID: 100413
[No Abstract] [Full Text] [Related]
30. Primary structure of human gamma 3 immunoglobulin deletion mutant: gamma 3 heavy-chain disease protein Wis.
Frangione B; Rosenwasser E; Prelli F; Franklin EC
Biochemistry; 1980 Sep; 19(18):4304-8. PubMed ID: 6774747
[TBL] [Abstract][Full Text] [Related]
31. Sequential development of Waldenström's macroglobulinemia and gamma-1-heavy chain disease in a single patient. Clinical, immunochemical, immunofluorescent and protein studies.
Ockhuizen T; Jilderda JF; Cazemier T
Acta Haematol; 1984; 71(1):53-9. PubMed ID: 6419527
[TBL] [Abstract][Full Text] [Related]
32. STRUCTURAL STUDIES OF HUMAN 7S GAMMA-GLOBULIN (G IMMUNOGLOBULIN). FURTHER OBSERVATIONS OF A NATURALLY OCCURRING PROTEIN RELATED TO THE CRYSTALLIZABLE (FAST) FRAGMENT.
FRANKLIN EC
J Exp Med; 1964 Nov; 120(5):691-709. PubMed ID: 14247713
[TBL] [Abstract][Full Text] [Related]
33. Deleted IgG1 and IgG2 H chains in a patient with an IgG subclass imbalance.
Lebreton JP; Fontaine M; Rousseaux J; Youinou P; Hurez D; Rivat-Peran L; Bernards JP
Clin Exp Immunol; 1982 Jan; 47(1):206-16. PubMed ID: 6807588
[TBL] [Abstract][Full Text] [Related]
34. [Isolation of a gamma heavy chain fragment from normal human serum].
Irurzun PL; Miranda MP
Allergol Immunopathol (Madr); 1976; 4(2):111-20. PubMed ID: 820178
[TBL] [Abstract][Full Text] [Related]
35. Rheumatoid arthritis associated with transient gamma 2-heavy chain disease.
Ockhuizen T; Smit JW; van Leeuwen M
Rheumatol Int; 1983; 3(4):167-72. PubMed ID: 6422533
[TBL] [Abstract][Full Text] [Related]
36. Gamma-chain heavy-chain disease with primary thyroid plasmacytoma.
Ottó S; Péter I; Végh S; Juhos E; Besznyák I
Arch Pathol Lab Med; 1986 Oct; 110(10):893-6. PubMed ID: 3094476
[TBL] [Abstract][Full Text] [Related]
37. Determinants recognized by murine rheumatoid factors: molecular localization using a panel of mouse myeloma variant immunoglobulins.
Stassin V; Coulie PG; Birshtein BK; Secher DS; Van Snick J
J Exp Med; 1983 Nov; 158(5):1763-8. PubMed ID: 6195294
[TBL] [Abstract][Full Text] [Related]
38. G1 heavy chain disease: clinicopathological, ultrastructural and immunochemical study of a new case.
Stramignoni A; Carbonara A; Paolino W; Navone R; Coda R; Leonardo E
J Cancer Res Clin Oncol; 1980 Jan; 96(1):93-103. PubMed ID: 6766944
[TBL] [Abstract][Full Text] [Related]
39. [Immunochemical study of serum in the diagnosis of mu-chain disease].
Chernokhvostova EV; Batalova TN; Andreeva NE; Antipova LG
Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):42-8. PubMed ID: 404805
[TBL] [Abstract][Full Text] [Related]
40. Immunoselection screening methods for detection of the free heavy chains.
Ottó S; Végh Z; Kocsis G
Immunol Lett; 1984; 8(4):211-4. PubMed ID: 6437970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
